# US 2025/0164499 A1 · Macromolecule analysis employing nucleic acid encoding

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0164499 A1
- Document ID: US20250164499A1
- Status: Published application
- Kind: A1
- Application number: 19/030,023
- Filed: 2025-01-17
- Published: 2025-05-22
- Earliest claimed: 2016-05-02
- Assignees: Encodia, Inc.
- Applicants: Encodia, Inc.
- Inventors: Mark S. CHEE; Kevin L. GUNDERSON; Michael Phillip WEINER
- Web page: https://patentgrep.com/patent/US20250164499A1

## CPC

- G01N 33/6824: {involving N-terminal degradation, e.g. Edman degradation}
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- C40B 40/10: Libraries containing peptides or polypeptides, or derivatives thereof
- C40B 70/00: Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes
- G01N 33/6803: {General methods of protein analysis not limited to specific proteins or families of proteins}
- G01N 33/6842: {Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins}
- G01N 33/6845: {Methods of identifying protein-protein interactions in protein mixtures}
- G01N 2458/00: Labels used in chemical analysis of biological material
- G01N 2458/10: Oligonucleotides as tagging agents for labelling antibodies
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

A method for analyzing macromolecules, including peptides, polypeptides, and proteins, employing nucleic acid encoding is disclosed.

## Claims

### Claim at position 1

1-177. (canceled)

### Claim 178

A method for analyzing a macromolecule, the method comprising:
(a) contacting the macromolecule or a first component thereof with a first binding agent, wherein the macromolecule or the first component thereof is associated with a nucleic acid recording tag joined to a solid support, wherein the first binding agent is associated with a first nucleic acid coding tag that comprises a first encoder sequence comprising identifying information regarding the first binding agent, and
wherein the first binding agent binds to the first component of the macromolecule;
(b) transferring the first encoder sequence to the nucleic acid recording tag to generate an extended nucleic acid recording tag on the solid support;
(c) contacting the macromolecule or a second component thereof with a second binding agent,
wherein the second binding agent is associated with a second nucleic acid coding tag that comprises a second encoder sequence comprising identifying information regarding the second binding agent, and wherein the second binding agent binds to the second component of the macromolecule;
(d) transferring the second encoder sequence to the extended recording tag to generate a further extended recording tag on the solid support; and
(e) analyzing the further extended recording tag, wherein analyzing comprises a sequencing method, and obtaining the identifying information regarding the first binding agent and the identifying information regarding the second binding agent, thereby analyzing the macromolecule.

### Claim 179 (depends on 178)

The method of claim 178, wherein contacting steps (a) and (c) are performed in sequential order.

### Claim 180 (depends on 178)

The method of claim 178, wherein contacting steps (a) and (c) are performed at the same time.

### Claim 181 (depends on 178)

The method of claim 178, wherein the first binding agent and the second binding agent each comprise a peptide or an aptamer.

### Claim 182 (depends on 178)

The method of claim 178, wherein the macromolecule or the first component thereof is covalently joined to the nucleic acid recording tag before the macromolecule or the first component thereof is joined to the solid support.

### Claim 183 (depends on 178)

The method of claim 178, wherein the nucleic acid recording tag is covalently joined to the solid support before step (a).

### Claim 184 (depends on 178)

The method of claim 178, wherein the solid support is a bead.

### Claim 185 (depends on 178)

The method of claim 178, wherein the transferring in step (b) and step (d) comprise primer extension.

### Claim 186 (depends on 178)

The method of claim 178, wherein the transferring in step (b) and step (d) comprise ligation.

### Claim 187 (depends on 178)

The method of claim 178, wherein the nucleic acid recording tag comprises a macromolecule barcode.

### Claim 188 (depends on 178)

The method of claim 178, wherein the nucleic acid recording tag further comprises a sample barcode.

### Claim 189 (depends on 178)

The method of claim 178, wherein the nucleic acid recording tag comprises a spacer at its terminus, wherein the spacer has a sequence complementary to a sequence of a second spacer in the first nucleic acid coding tag.

### Claim 190 (depends on 178)

The method of claim 178, wherein the macromolecule comprises a macromolecule assembly comprising the first component and the second component.

### Claim 191 (depends on 190)

The method of claim 190, wherein the first component comprises a first protein and the second component comprises a second protein.

### Claim 192 (depends on 190)

The method of claim 190, wherein the first component comprises a nucleic acid and the second component comprises a first protein.

### Claim 193 (depends on 190)

The method of claim 190, wherein the first component comprises a posttranslational modification of the first protein.

### Claim 194 (depends on 178)

The method of claim 178, wherein in step (a), 100 or more different macromolecules are each associated with a nucleic acid recording tag joined to the support, and wherein the 100 or more different macromolecules are analyzed simultaneously.

### Claim 195 (depends on 178)

The method of claim 178, wherein the first binding agent forms a non-covalent association with the first component of the macromolecule and the second binding agent forms a non-covalent association with the second component of the macromolecule.

### Claim 196 (depends on 178)

The method of claim 178, wherein the macromolecule is a peptide, and wherein the first component of the peptide and the second component of the peptide each comprises one or more amino acids of the peptide.

### Claim 197 (depends on 196)

The method of claim 196, wherein the peptide is obtained by fragmenting a protein from a biological sample.

### Claim 198 (depends on 196)

The method of claim 196, wherein the first component of the peptide and/or the second component of the peptide comprise a terminal amino acid (TAA) of the peptide.

### Claim 199 (depends on 196)

The method of claim 196, wherein the first binding agent binds to a terminal amino acid (TAA) or a modified TAA of the peptide or the first component thereof.

### Claim 200 (depends on 196)

The method of claim 196, wherein the second binding agent binds to a terminal amino acid (TAA) or a modified TAA of the peptide or the second component thereof.

### Claim 201 (depends on 200)

The method of claim 200, further comprising the following step: modifying an N-terminal amino acid (NTAA) of the peptide with a chemical moiety before performing step (a) to produce a modified NTAA, wherein the first binding agent binds to the modified NTAA.

### Claim 202 (depends on 201)

The method of claim 201, further comprising the following step: (bc) removing the modified NTAA to generate the second component of the peptide comprising a new NTAA, and modifying the new NTAA of the second component of the peptide with a chemical moiety to yield a newly modified NTAA, wherein the step (bc) is performed before step (c) and after step (b), and wherein the second binding agent binds to the newly modified NTAA of the peptide.

### Claim 203 (depends on 196)

The method of claim 196, wherein the analyzing step (e) comprises determining an amino acid sequence of the peptide.

### Claim 204 (depends on 196)

The method of claim 196, wherein analyzing the further extended recording tag comprises determining an amino acid sequence of the first component of the peptide and an amino acid sequence of the second component of the peptide.

### Claim 205 (depends on 204)

The method of claim 204, wherein the determined amino acid sequence of the first component of the peptide and the determined amino acid sequence of the second component of the peptide are mapped back to a proteome or a subset of the proteome from which the peptide originates.

### Claim 206 (depends on 178)

The method of claim 178, wherein the macromolecule comprises a lipid, a carbohydrate, or a macrocycle.
